Allergic Conjunctivitis Market is estimated to be valued at US$ 2,486.7 million in 2021 and is expected to exhibit a CAGR of 5.4% during the forecast period (2021-2028)

Overview

Antihistamines can ease the symptoms of allergic conjunctivitis. Some of the most commonly prescribed antihistamines include loratadine and fexofenadine. A doctor can also use an allergy panel to confirm the diagnosis. The test can help pinpoint the allergen causing the symptoms. Usually, the symptoms are persistent and can last for many years. The severity of allergic conjunctivitis varies depending on the severity of the condition and the person’s genetics. The results of a laboratory study usually indicate the presence of one or more allergens. People with this condition can experience increased itching and eyelid swelling. They may also experience itching and burning.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4570

Competitive Landscape

Major companies contributing to the global allergic conjunctivitis market include Ocular Therapeutix, Inc., Bausch & Lomb Incorporated., Alcon, Sun Pharmaceutical Industries Ltd., Auven Therapeutics, Eton Pharmaceutical, Atopix Therapeutics Ltd., Novartis AG., Santen Pharmaceutical Co., Ltd., Allergan, and Eyevance Pharmaceuticals LLC.

Drivers

Increasing occurrences of ocular allergies in urban spaces due to rising air pollution, in tandem with the growing number of allergens in the air are expected to drive the growth of the allergic conjunctivitis market throughout the forecast period.

Furthermore, the advent of new therapies and drugs for treating ocular disorders is expected to aid the growth of the allergic conjunctivitis market during the forecast period.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4570

Summary of the COVID-19 Debacle

The global allergic conjunctivitis market experienced a steep fall in demand due to the prevalence of the COVID-19 pandemic. The crisis-driven social distancing measures instigated the patients as well as the ophthalmologists to switch to virtual consultations in lieu of in-person meetings at vision care centers. On the brighter side, the market is performing well at current levels considering the progressive vaccination drives.

Key Takeaways

• The allergic conjunctivitis market is anticipated to grow at a CAGR of 5.4 % during the forecast period owing to the increasing research and development activities and an expanding biotechnology sector. For instance, in July 2020, the National Institute of Health (NIH) reported that about 1% to 3% of COVID-19 patients are likely to develop allergic conjunctivitis or pinkeye as a potential symptom.
• In geographic news, the North American region is estimated to come up as a clear leader in the global allergic conjunctivitis market on the heels of growing prevalence of ocular disorders in children and senescent population combined with accelerated approval pathways for newer drugs.
• Also standing out in the global allergic conjunctivitis market is the Asia Pacific region, which is propelled by mounting cases of eye disorders, improving healthcare facilities in rural areas, and increasing awareness of ocular allergies.

Reasons to Purchase this Report

• Current and future of global Allergic Conjunctivitis Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/4570

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Class
     • Market Snapshot, By Disease Type
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
   • Impact Analysis
   • Pipeline Analysis
   • Regulatory Scenario
   • Market Trends
   • Key Developments
   • Epidemiology
   • PEST Analysis
   • Brand Analysis
4. Global Allergic Conjunctivitis Market– Impact of Coronavirus (COVID-19) Pandemic
   • Economic Impact
   • Impact on Clinical Trials and Drug Development
5. Global Allergic Conjunctivitis Market, By Drug Class, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Antihistamines & Mast Cell Stabilizers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
6. Global Allergic Conjunctivitis Market, By Disease Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Mild Allergic Conjunctivitis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Severe Allergic Conjunctivitis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
7. Global Allergic Conjunctivitis Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
8. Global Allergic Conjunctivitis Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • U.K.
       • Germany
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa

View Press Release: https://www.coherentmarketinsights.com/press-release/allergic-conjunctivitis-market-3812

About Us: